Andre Ziegler

Title: Andre Ziegler: Innovator in Stroke Prediction and Atrial Fibrillation

Introduction

Andre Ziegler is a notable inventor based in Laeufelfingen, Switzerland. He has made significant contributions to the field of medical diagnostics, particularly in predicting stroke risk and atrial fibrillation recurrence. With a total of 8 patents to his name, Ziegler's work has the potential to impact patient care and treatment outcomes.

Latest Patents

Ziegler's latest patents include innovative methods for predicting the risk of stroke and recurrence of atrial fibrillation. One of his patents focuses on the use of circulating Angiopoietin-2 (Ang-2) and insulin-like growth factor-binding protein 7 (IGFBP7) to enhance the accuracy of clinical stroke risk scores. This method involves determining the levels of these biomarkers in a subject's sample. Another patent addresses the prediction of atrial fibrillation recurrence by measuring Ang-2 levels, providing a diagnostic tool for healthcare professionals.

Career Highlights

Throughout his career, Ziegler has worked with prominent companies in the diagnostics field, including Roche Diagnostics Operations, Inc. and Roche Diagnostics GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.

Collaborations

Ziegler has collaborated with various professionals in his field, including Ursula-Henrike Wienhues-Thelen and Dirk Block. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Andre Ziegler's contributions to medical diagnostics through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for improved patient outcomes in stroke and atrial fibrillation management.